University of Maryland Eastern Shore - Land-Grant Institution - Funding (Land-Grant Equity and Accountability Act)
HB0884 would create a new section of Maryland health law restricting the sale of over-the-counter “diet pills” to minors. The bill defines diet pills broadly to include certain dietary supplements and nonprescription drugs marketed for weight loss or muscle building, while excluding items such as dietary fiber and most protein products. It would prohibit selling, transferring, or furnishing these products to anyone under 18 unless the minor is accompanied by a parent or guardian, and it would require retailers to keep diet pills in employee-only areas such as behind a counter or in a locked case.
The bill also imposes special requirements on delivery sales, including age verification at delivery, a signature from an adult 18 or older at the delivery address, and packaging that clearly indicates the contents contain a diet pill. Retailers and delivery sellers would have to request identification when a purchaser appears under 18, and courts could consider a range of ingredients, labels, marketing claims, and store placement when deciding whether a product qualifies as a diet pill. Violations would be subject to civil penalties of up to $750 per violation, and the bill exempts news media from liability for carrying advertisements for diet pills.
HB0884 would add a new public health restriction to the Health – General Article and also amend existing penalty provisions so that violations of the new diet-pill section are excluded from a separate misdemeanor/civil penalty framework in Subtitle 2. In practice, the bill would affect retailers, online sellers, delivery services, and manufacturers or marketers of weight-loss and muscle-building supplements and nonprescription drugs by imposing age-gating, display, shipping, and identification requirements. It would also give courts guidance on how to determine whether a product is covered, potentially affecting enforcement against products marketed with weight-loss or muscle-building claims.
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the bill appears to be framed as a consumer- and youth-protection measure aimed at limiting minors’ access to potentially risky weight-loss products. The overall tone of the legislation is regulatory and precautionary rather than punitive, with a relatively modest civil penalty structure and an explicit carve-out for news media advertising. No contrary viewpoints are documented in the provided context.
The main points of potential contention are the breadth of the definition of “diet pills” and the practical burden on retailers and online sellers. The bill sweeps in a wide range of supplements and nonprescription drugs based on ingredients, labeling, marketing, and even store placement, which could raise questions about overinclusion or enforcement uncertainty. Retailers and delivery sellers may object to the requirement to verify age, restrict access, and use adult-signature shipping procedures, while supporters would likely emphasize the public health rationale for limiting minors’ access to weight-loss and muscle-building products. No specific opposing or supporting speakers are identified in the provided record.